LENSAR, Inc. (LNSR)

Name: LENSAR, Inc. (LNSR) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001320350 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, LENSAR, Inc. reported revenue of $58.44M. Revenue grew 9.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $60.26M.

Key ratios (year ended 2025-12-31)

46.4%

Gross margin (computed)

-42.1%

Operating margin

-58.7%

Net margin

9.2%

Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Revenue	$60.26M	$58.44M	$53.49M	$42.16M	$35.36M	$34.46M	$26.38M	$30.53M
Cost of Revenue	$31.13M	$31.31M	$27.64M	$21.06M	$15.40M	$16.63M	$12.31M	$17.30M
Gross Profit (computed)	$29.13M	$27.12M	$25.85M	$21.11M	$19.95M	$17.83M	$14.07M	$13.23M
R&D Expense	$5.32M	$5.62M	$5.33M	$6.14M	$11.81M	$12.36M	$7.55M	$7.57M
Operating Income	-$8.13M	-$24.58M	-$10.66M	-$12.23M	-$20.18M	-$19.65M	-$18.50M	-$12.71M
Net Income	$34.70M	-$34.28M	-$31.40M	-$14.38M	-$19.91M	-$19.60M	-$19.77M	-$14.66M
EPS (Diluted)	n/a	-$2.87	-$2.73	-$1.31	-$1.96	-$2.09	n/a	n/a
Total Assets	$69.56M	$71.43M	$66.30M	$69.58M	$55.84M	$66.47M	$79.12M	$34.54M
Total Liabilities	$40.87M	$83.67M	$47.65M	$22.41M	$13.86M	$11.59M	$11.91M	$65.09M
Shareholders' Equity	$14.90M	-$26.02M	$4.86M	$33.43M	$41.98M	$54.88M	$67.21M	-$30.55M
Cash & Equivalents	$13.56M	$12.97M	$16.26M	$20.62M	$14.67M	$31.64M	$40.60M	$4.62M
Operating Cash Flow	-$7.29M	-$14.83M	-$2.27M	-$9.66M	-$14.86M	-$8.97M	-$13.79M	-$12.59M
Capital Expenditures	$35.0K	$83.0K	$156.0K	$236.0K	$115.0K	$354.0K	$366.0K	$389.0K
Free Cash Flow	-$7.33M	-$14.91M	-$2.43M	-$9.89M	-$14.97M	-$9.32M	-$14.16M	-$12.98M
Shares Outstanding	12.28M	11.99M	11.65M	11.33M	11.09M	10.99M	10.93M	1.07M
Weighted Average Diluted Shares	n/a	11.96M	11.52M	10.97M	10.16M	9.37M	n/a	n/a
EPS (Basic)	n/a	-$2.87	-$2.73	-$1.31	-$1.96	-$2.09	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView